V. Diéras

Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

H. S. Rugo, Sherene Loi, Sylvia Adams et al. · Annals of Oncology · 2019 · 113 citations · Full text

Breast Oncology, Health Sciences, Medicine +10

A meta-analysis of overall survival data from three randomized trials of bevacizumab (BV) and first-line chemotherapy as treatment for patients with metastatic breast cancer (MBC).

J. O’Shaughnessy, David Miles, Robert J. Gray et al. · Journal of Clinical Oncology · 2010 · 110 citations

Breast Oncology, Cancer Management, Clinical Endpoint +19

REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours

Christelle Lévy, Djelila Allouache, Joëlle Lacroix et al. · Annals of Oncology · 2014 · 58 citations · Full text

Neuro-oncology, Radiation Therapy, Medicine +9

Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma

Jean‐Paul Guastalla, Éric Pujade-Lauraine, B. Weber et al. · Annals of Oncology · 1998 · 43 citations · Full text

Carboplatin Combination, Medicine, Cancer Management +9

Abstract P3-14-01: A Phase Ib/II Trial of Trastuzumab-DM1 with Pertuzumab for Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer: Interim Efficacy and Safety Results

V. Diéras, Nadia Harbeck, Kathy S. Albain et al. · Cancer Research · 2010 · 38 citations

Breast Oncology, Immunology, Pathology +19